XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 22,464 $ 36,828
Adjustments to reconcile net income to cash flows from operating activities:    
Depreciation and amortization 7,421 8,056
Share-based compensation expense 22,810 32,755
Deferred income taxes 2,507 7,515
Other non-cash charges 274 2,215
Changes in assets and liabilities:    
Receivables 65,825 16,628
Contract assets 1,941 (523)
Inventory (1,751) (12,641)
Prepaid expenses and other assets (844) (7,461)
Right-of-use assets 1,840 1,777
Accounts payable and accrued expenses (1,681) (38,448)
Accrued sales discounts, allowances and reserves (22,657) (22,764)
Contract liabilities 359 (208)
Operating lease liabilities (2,548) (2,516)
Other long-term liabilities 2,851 (105)
Cash flows provided by operating activities 98,811 21,108
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additions of property, plant and equipment (10,110) (8,342)
Proceeds from the sale of property, plant and equipment 1,713 411
Purchases of investments (95,988) (114,508)
Sales and maturities of investments 113,487 82,488
Cash flows provided by (used in) investing activities 9,102 (39,951)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of ordinary shares under share-based compensation arrangements 29,528 11,226
Employee taxes paid related to net share settlement of equity awards (28,781) (28,349)
Principal payments of long-term debt   (750)
Cash flows provided by (used in) financing activities 747 (17,873)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 108,660 (36,716)
CASH AND CASH EQUIVALENTS—Beginning of period 291,146 457,469
CASH AND CASH EQUIVALENTS—End of period 399,806 420,753
Non-cash investing and financing activities:    
Purchased capital expenditures included in accounts payable and accrued expenses $ 5,911 $ 2,629